Customer introductions
Relevant operating businesses within the family network.
When the X-Ray says Hold, Support or Intervene, VIV builds a focused 90-day value agenda around the actual constraint — revenue, GCC entry, distribution, talent, follow-on capital, manufacturing, strategic partnership or buyer access — and activates the family capability network against it.
Discuss a 90-day interventionRelevant operating businesses within the family network.
India → UAE/GCC first, then other corridors as the network matures.
Retail, FMCG, healthcare, industrial and other family-owned channels.
CFO, sales leadership, board and operating expertise.
Relevant investor introductions where mandates fit.
JVs, manufacturing, supply relationships and strategic acquirers.
We do not sell vague “portfolio support.” A mandate should define the constraint — for example GCC revenue, distributor access, CFO hiring, manufacturing partner or strategic-buyer preparation — and measure whether the intervention changed it.
Tell us enough to understand the problem. We use the information to route the conversation to the relevant VIV service; it is not a public deal submission.
Intervene where one solvable constraint can materially change portfolio value.
The engine asks only the facts needed for this service, identifies missing evidence, gives a first-pass diagnostic and routes the user into the relevant VIV workflow. It is not a generic lead form.
Relationships are tagged by what they can actually contribute—customers, distribution, operating expertise, geography, strategic appetite, talent or capital—so access is activated by fit rather than by contact count.
Interventions are categorized by bottleneck and measured by subsequent outcome, helping VIV learn when customer access, talent, governance, capital or strategic support is most likely to matter.
Families and portfolio companies participate through explicit mandates and permissions. Useful access compounds without turning the network into a public marketplace.
A strong portfolio company has product-market evidence but weak enterprise access. VIV defines the target customer and use case, then activates relevant customer and distribution pathways with measurable 30/60/90-day outcomes.
An Indian portfolio company wants UAE or Saudi growth. VIV tests the entry thesis, maps localization and buyer requirements, qualifies commercial pathways and uses the family/capability network only where there is a specific fit.
A family had a portfolio company whose operating performance was not matching the original investment thesis. Rather than launch a broad advisory programme, VIV isolated the constraint most likely to change enterprise value and built a 90-day intervention around it. The family and company worked from one objective, named owners, measurable milestones and a clear decision at the end of the intervention: scale the pathway, adapt it or stop.
Client-identifying details and commercially sensitive information are withheld for confidentiality.